Sign in

Phathom Pharmaceuticals, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total revenue 0.18 0.06 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.02 0.01 0.00 0.00 0.00 0.00 0.00
Gross profit 0.15 0.05 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.31 0.32 0.17 0.17 0.13 0.13 0.11 0.00
Operating income -0.16 -0.28 -0.17 -0.17 -0.14 -0.13 -0.11 0.00
Non-operating income (net) -0.06 -0.06 -0.03 -0.03 -0.01 0.00 -0.15 0.00
Income before tax -0.22 -0.33 -0.20 -0.20 -0.14 -0.13 -0.26 0.00
Income tax expense 0.04 0.03 0.00 0.00 -0.05 0.00
Net income -0.22 -0.33 -0.20 -0.20 -0.14 -0.13 -0.21 0.00
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total revenue 0.06 0.06 0.05 0.04 0.03 0.03 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.05 0.05 0.04 0.03 0.02 0.03 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.06 0.06 0.06 0.09 0.10 0.09 0.08 0.08 0.07 0.07 0.04 0.03 0.03 0.05 0.04 0.05 0.04 0.03 0.03 0.04 0.03 0.05 0.03 0.02 0.02 0.02 0.01 0.08 0.00 0.00 0.00 0.00 0.00
Operating income -0.02 -0.01 -0.02 -0.06 -0.08 -0.06 -0.07 -0.08 -0.07 -0.07 -0.04 -0.03 -0.03 -0.05 -0.04 -0.05 -0.04 -0.03 -0.03 -0.04 -0.03 -0.05 -0.03 -0.02 -0.02 -0.02 -0.01 -0.08 0.00 0.00 0.00 0.00 0.00
Non-operating income (net) -0.01 -0.02 -0.01 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.08 -0.06 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.03 -0.02 -0.03 -0.08 -0.09 -0.07 -0.09 -0.09 -0.08 -0.08 -0.04 -0.04 -0.04 -0.06 -0.05 -0.05 -0.04 -0.04 -0.04 -0.04 -0.03 -0.05 -0.03 -0.02 -0.02 -0.10 -0.07 -0.09 0.00 0.00 0.00 0.00 0.00
Income tax expense 0.00 -0.02 0.01 0.01 0.00 0.01 0.01 0.01 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.03 -0.02 -0.03 -0.08 -0.09 -0.07 -0.09 -0.09 -0.08 -0.08 -0.04 -0.04 -0.04 -0.06 -0.05 -0.05 -0.04 -0.04 -0.04 -0.04 -0.03 -0.05 -0.03 -0.02 -0.02 -0.10 -0.07 -0.09 0.00 0.00 0.00 0.00 0.00
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total cash and short-term investments + 0.13 0.30 0.38 0.16 0.18 0.29 0.24 0.00
Accounts receivable, net 0.08 0.04 0.00 0.00 0.00
Inventories 0.01 0.00 0.00 0.00 0.00
Other current assets 0.02 0.02 0.01 0.01 0.00 0.00 0.01 0.00
Total current assets 0.23 0.36 0.40 0.16 0.19 0.29 0.26 0.00
Total non-current assets + 0.03 0.02 0.02 0.00 0.00 0.00 0.00 0.00
Total assets 0.26 0.38 0.41 0.16 0.19 0.30 0.26 0.00
Total current liabilities + 0.13 0.09 0.04 0.03 0.02 0.06 0.00 0.00
Total non-current liabilities + 0.57 0.55 0.45 0.21 0.10 0.05 0.03 0.00
Total liabilities 0.70 0.63 0.49 0.24 0.12 0.10 0.03 0.00
Total stockholders' equity + -0.44 -0.25 -0.07 -0.07 0.07 0.19 0.23 0.00
Common shares outstanding 73 63 51 39 37 33 25 9
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total cash and short-term investments + 0.18 0.13 0.14 0.15 0.21 0.30 0.33 0.28 0.32 0.38 0.21 0.25 0.13 0.16 0.20 0.21 0.14 0.18 0.22 0.21 0.24 0.29 0.23 0.25 0.26 0.24 0.07 0.08 0.00 0.00 0.00 0.00 0.00
Accounts receivable, net 0.08 0.08 0.06 0.05 0.04 0.04 0.02 0.01 0.00 0.00 0.00 0.00
Inventories 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.01 0.02 0.01 0.01 0.01 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00
Total current assets 0.28 0.23 0.21 0.22 0.26 0.36 0.37 0.30 0.34 0.40 0.23 0.26 0.14 0.16 0.20 0.21 0.15 0.19 0.23 0.21 0.24 0.29 0.23 0.25 0.26 0.26 0.08 0.08 0.00 0.00 0.00
Total non-current assets + 0.03 0.03 0.03 0.03 0.03 0.02 0.01 0.01 0.02 0.02 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 0.31 0.26 0.24 0.25 0.29 0.38 0.39 0.32 0.36 0.41 0.24 0.27 0.14 0.16 0.20 0.21 0.15 0.19 0.23 0.21 0.25 0.30 0.23 0.25 0.26 0.26 0.08 0.08 0.08 0.00 0.00
Total current liabilities + 0.13 0.13 0.09 0.09 0.07 0.09 0.07 0.05 0.04 0.04 0.02 0.02 0.01 0.03 0.02 0.02 0.01 0.02 0.03 0.04 0.04 0.06 0.03 0.01 0.00 0.00 0.21 0.14 0.14 0.00 0.00
Total non-current liabilities + 0.52 0.57 0.57 0.56 0.56 0.55 0.51 0.51 0.46 0.45 0.23 0.23 0.22 0.21 0.21 0.20 0.10 0.10 0.10 0.04 0.04 0.05 0.05 0.05 0.05 0.03 0.02 0.02
Total liabilities 0.64 0.70 0.66 0.66 0.63 0.63 0.57 0.55 0.51 0.49 0.25 0.25 0.23 0.24 0.23 0.22 0.11 0.12 0.12 0.08 0.08 0.10 0.07 0.06 0.06 0.03 0.23 0.17 0.17 0.00 0.00
Total stockholders' equity + -0.34 -0.44 -0.42 -0.41 -0.34 -0.25 -0.19 -0.23 -0.15 -0.07 -0.02 0.02 -0.09 -0.07 -0.03 -0.01 0.04 0.07 0.10 0.13 0.16 0.19 0.16 0.19 0.21 0.23 -0.15 -0.08 0.00 0.00 0.00
Common shares outstanding 82 74 73 72 72 71 65 59 58 51 57 49 42 41 39 38 38 38 37 37 36 34 33 33 32 32 23 9 9 9 9 5 5
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Operating cash flow + -0.17 -0.27 -0.14 -0.15 -0.15 -0.07 -0.04 0.00
Cash flow from investing + 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 -0.03
Cash flow from financing + 0.00 0.18 0.37 0.12 0.04 0.11 0.30 0.00
Change in cash -0.17 -0.08 0.23 -0.03 -0.10 0.04 0.24 -0.02
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Operating cash flow + -0.02 -0.01 -0.01 -0.06 -0.08 -0.06 -0.06 -0.07 -0.07 -0.04 -0.03 -0.02 -0.04 -0.04 -0.04 -0.03 -0.04 -0.04 -0.03 -0.03 -0.05 -0.03 -0.02 -0.01 -0.01 -0.02 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00
Cash flow from investing + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 0.00 -0.01 -0.01
Cash flow from financing + 0.07 0.00 0.00 0.00 0.00 0.03 0.12 0.02 0.01 0.21 0.00 0.14 0.01 0.14 0.02 0.10 0.10 0.00 0.04 0.00 0.00 0.09 0.03 0.09 0.03 0.19 0.00 0.11 0.00 0.00 0.00 0.00 0.00
Change in cash 0.05 -0.01 -0.01 -0.06 -0.08 -0.04 0.06 -0.05 -0.06 0.17 -0.03 0.12 -0.03 0.10 -0.01 0.07 0.05 -0.04 0.01 -0.03 -0.05 0.06 0.00 0.08 0.01 0.17 -0.01 0.08 0.00 -0.01 -0.01 0.00 0.00
5 days ago

Phathom Pharmaceuticals, Inc. (PHAT) - Other Non Operating Income

1Y 2Y 5Y Max
9 days ago

Phathom Pharmaceuticals, Inc. (PHAT) - Income Tax Expense

1Y 2Y 5Y Max
9 days ago

Phathom Pharmaceuticals, Inc. (PHAT) - Net Income

1Y 2Y 5Y Max
9 days ago

Phathom Pharmaceuticals, Inc. (PHAT) - Ebitda

1Y 2Y 5Y Max
9 days ago

Phathom Pharmaceuticals, Inc. (PHAT) - Ebit

1Y 2Y 5Y Max
9 days ago

Phathom Pharmaceuticals, Inc. (PHAT) - Net Income From Continuing Operations

1Y 2Y 5Y Max
9 days ago

Phathom Pharmaceuticals, Inc. (PHAT) - Income Before Tax

1Y 2Y 5Y Max
9 days ago

Phathom Pharmaceuticals, Inc. (PHAT) - Depreciation And Amortization

1Y 2Y 5Y Max
9 days ago

Phathom Pharmaceuticals, Inc. (PHAT) - Interest Expense

1Y 2Y 5Y Max
9 days ago

Phathom Pharmaceuticals, Inc. (PHAT) - Interest Income

1Y 2Y 5Y Max
9 days ago